3.91000 EUR
0.18
4.40%
Last update Dec 16, 7:32 PM CET
Market closed
Day range
3.91000
4.13800
Previous close
4.090000
Open
4.12000
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
3.91
0.18
4.40%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023
Total reported revenue 5.3M 18.1M
Cost of revenue
Gross profit
Operating expense
Research & development 46.1M 73.7M
Selling general and admin 18.8M 22.5M
Other operating expenses
Operating income -59.6M -78.0M
Non operating interest income
Income 5.6M 5.7M
Expense 116.8K 459K
Other income expense -5.4M -44K
Pretax income -59.6M -72.8M
Tax provision 0 0
Net income -59.6M -72.8M
Basic EPS -0.4 -0.4
Diluted EPS -0.4 -0.4
Basic average shares 158.2M 178.4M
Diluted average shares 158.2M 178.4M
EBITDA -52.8M -70.9M
Net income from continuing op. -59.6M -72.8M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 24 minutes

23:35
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).